Literature DB >> 12480794

Donepezil-treated patients with probable vascular dementia demonstrate cognitive benefits.

Raymond D Pratt1, C A Perdomo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480794     DOI: 10.1111/j.1749-6632.2002.tb04859.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  13 in total

1.  Clinical trials in stroke in 2002.

Authors:  Meheroz H Rabadi; John Blass
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

Review 2.  Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature.

Authors:  J Helen Yoo; Maria G Valdovinos; Dean C Williams
Journal:  J Autism Dev Disord       Date:  2007-01-13

3.  Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia.

Authors:  Stefan Smesny; Susan Stein; Ingo Willhardt; Jürgen Lasch; Heinrich Sauer
Journal:  J Neural Transm (Vienna)       Date:  2008-06-27       Impact factor: 3.575

4.  Guidelines for the treatment of Alzheimer's disease from the Italian Association of Psychogeriatrics.

Authors:  Carlo Caltagirone; Angelo Bianchetti; Monica Di Luca; Patrizia Mecocci; Alessandro Padovani; Elvezio Pirfo; Pierluigi Scapicchio; Umberto Senin; Marco Trabucchi; Massimo Musicco
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Donepezil: in vascular dementia.

Authors:  David R Goldsmith; Lesley J Scott
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 6.  Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.

Authors:  Juan Wang; Hai-Yan Zhang; Xi-Can Tang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

7.  Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.

Authors:  Gary Small; Timo Erkinjuntti; Alexander Kurz; Sean Lilienfeld
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.

Authors:  Ceri E Battle; Azmil H Abdul-Rahim; Susan D Shenkin; Jonathan Hewitt; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2021-02-22

9.  Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients.

Authors:  Bernhard Rosengarten; Sönke Paulsen; Sandor Molnar; Reiner Kaschel; Bernd Gallhofer; Manfred Kaps
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 6.682

10.  Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review.

Authors:  Frank J Molnar; Malcolm Man-Son-Hing; Brian Hutton; Dean A Fergusson
Journal:  Open Med       Date:  2009-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.